International Biotechnology (IBT) Competitors GBX 684 0.00 (0.00%) As of 06:06 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock IBT vs. ICGT, IEM, RICA, CGT, MUT, SAIN, JEO, APEO, VOF, and SDPShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include ICG Enterprise Trust (ICGT), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Capital Gearing (CGT), Murray Income Trust (MUT), Scottish American Investment (SAIN), European Opportunities Trust (JEO), abrdn Private Equity Opportunities (APEO), VinaCapital Vietnam Opp Fund (VOF), and Schroder Investment Trust - Schroder AsiaPacific Fund (SDP). These companies are all part of the "asset management" industry. International Biotechnology vs. Its Competitors ICG Enterprise Trust Impax Environmental Markets Ruffer Investment Capital Gearing Murray Income Trust Scottish American Investment European Opportunities Trust abrdn Private Equity Opportunities VinaCapital Vietnam Opp Fund Schroder Investment Trust - Schroder AsiaPacific Fund International Biotechnology (LON:IBT) and ICG Enterprise Trust (LON:ICGT) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Do institutionals and insiders hold more shares of IBT or ICGT? 45.2% of International Biotechnology shares are owned by institutional investors. Comparatively, 65.6% of ICG Enterprise Trust shares are owned by institutional investors. 4.2% of International Biotechnology shares are owned by company insiders. Comparatively, 12.3% of ICG Enterprise Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, IBT or ICGT? International Biotechnology has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, ICG Enterprise Trust has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Is IBT or ICGT a better dividend stock? International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.2%. ICG Enterprise Trust pays an annual dividend of GBX 34 per share and has a dividend yield of 2.4%. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. ICG Enterprise Trust pays out 67.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio. Is IBT or ICGT more profitable? International Biotechnology has a net margin of 90.66% compared to ICG Enterprise Trust's net margin of 58.54%. International Biotechnology's return on equity of 13.67% beat ICG Enterprise Trust's return on equity.Company Net Margins Return on Equity Return on Assets International Biotechnology90.66% 13.67% 3.57% ICG Enterprise Trust 58.54%2.61%0.78% Does the media prefer IBT or ICGT? In the previous week, ICG Enterprise Trust had 1 more articles in the media than International Biotechnology. MarketBeat recorded 2 mentions for ICG Enterprise Trust and 1 mentions for International Biotechnology. ICG Enterprise Trust's average media sentiment score of 1.84 beat International Biotechnology's score of 1.05 indicating that ICG Enterprise Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment International Biotechnology 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICG Enterprise Trust 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation & earnings, IBT or ICGT? International Biotechnology has higher earnings, but lower revenue than ICG Enterprise Trust. International Biotechnology is trading at a lower price-to-earnings ratio than ICG Enterprise Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInternational Biotechnology£41.82M5.88£37.91M£104.806.53ICG Enterprise Trust£55.63M16.76£32.56M£50.0828.80 SummaryICG Enterprise Trust beats International Biotechnology on 8 of the 15 factors compared between the two stocks. Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£245.70M£1.30B£6.49B£3.17BDividend Yield4.20%4.40%4.17%5.04%P/E Ratio6.5322.6214.32169.50Price / Sales5.882,455.101,764.82467,418.63Price / Cash155.7460.62127.5027.93Price / Book0.891.395.286.64Net Income£37.91M£265.04M£1.23B£5.89B7 Day Performance0.29%0.08%0.09%0.05%1 Month Performance7.89%1.44%2.66%49.82%1 Year Performance-0.29%6.84%24.28%148.65% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 684flatN/A+0.0%£245.70M£41.82M6.53N/APositive NewsICGTICG Enterprise TrustN/AGBX 1,455.19-0.1%N/A+16.7%£940.47M£55.63M29.06N/ANews CoveragePositive NewsIEMImpax Environmental MarketsN/AGBX 396.13+0.3%N/A+3.5%£919.62M£1.35M-98.53N/ANews CoverageRICARuffer InvestmentN/AGBX 284.50flatN/A+2.7%£915.45M£16.91M103.49N/ACGTCapital GearingN/AGBX 4,830.30-0.7%N/A+1.9%£898.31M£17.92M19.64N/AMUTMurray Income TrustN/AGBX 899-0.1%N/A+2.8%£898.18M£97.96M9.91147,000Dividend CutSAINScottish American InvestmentN/AGBX 510-1.0%N/A-0.6%£891.77M£75.38M10.23N/AJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/AAPEOabrdn Private Equity OpportunitiesN/AN/AN/AN/A£880.29M£80.21M1,435.00N/AVOFVinaCapital Vietnam Opp FundN/AGBX 495+0.2%N/A+5.3%£877.73M£115.59M13.20125News CoverageSDPSchroder Investment Trust - Schroder AsiaPacific FundN/AGBX 612+0.2%N/A+17.2%£864.55M£134.70M7.14N/ANews CoveragePositive News Related Companies and Tools Related Companies ICG Enterprise Trust Competitors Impax Environmental Markets Competitors Ruffer Investment Competitors Capital Gearing Competitors Murray Income Trust Competitors Scottish American Investment Competitors European Opportunities Trust Competitors abrdn Private Equity Opportunities Competitors VinaCapital Vietnam Opp Fund Competitors Schroder Investment Trust - Schroder AsiaPacific Fund Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IBT) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.